Investigating the Genetic Basis of Pseudoexfoliation Syndrome, Angle-closure Glaucoma and Primary Open-angle Glaucoma

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

There is increasing evidence that there are genetic risk factors for several forms of glaucoma, such as glaucoma caused by pseudoexfoliation syndrome (PXF) ,primary angle closure glaucoma (PACG) and primary open-angle glaucoma (POAG). The aim of the present prospective, multi-center, case-control study is to identify susceptibility genes/loci for PXF, PACG and POAG using a whole genome association (WGA) approach.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 21
Maximum Age: 105
Healthy Volunteers: t
View:

• For patients with PXF:

‣ Patients with confirmed pseudoexfoliation syndrome (exfoliation glaucoma / pseudoexfoliation of the lens) in the medical history

⁃ Informed consent

⁃ Age 50 years or more

• For patients with PACG:

‣ Patients with confirmed acute primary angle closure (PAC) or primary angle closure glaucoma (PACG) in the medical history

⁃ Informed consent

⁃ Age 21 years or more

• For healthy controls:

‣ No evidence of PXF, glaucoma or uveitis during clinical examination or in the medical history

⁃ No evidence of major ocular disease such as diabetic retinopathy, age related macular degeneration or conditions with genetic background during clinical examination or in the medical history

⁃ Age more than 60 years

⁃ Informed consent

• For patients with POAG:

‣ Patients with confirmed primary open angle glaucoma (POAG)

⁃ No evidence of exfoliation glaucoma / pseudoexfoliation of the lens or pigment glaucoma

⁃ Informed consent

⁃ Age 30 or more

Locations
Other Locations
Austria
Department of Clinical Pharmacology, Medical University of Vienna
RECRUITING
Vienna
Contact Information
Primary
Gerhard Garhöfer
gerhard.garhoefer@meduniwien.ac.at
0140 400 29880
Backup
Doreen Schmidl
doreen.schmidl@meduniwien.ac.at
0140 400 29880
Time Frame
Start Date: 2017-05-30
Estimated Completion Date: 2026-01-30
Participants
Target number of participants: 300
Treatments
Healthy controls
Healthy subjects with age more than 60 years
Pseudoexfoliation Glaucoma
Already diagnosed Pseudoexfoliation glaucoma patients with age more than 50 years
Angle closure Glaucoma
Already diagnosed Angle closure Glaucoma patients with age more than 21 years
Primary open-angle Glaucoma
Already diagnosed primary open-angle glaucoma with age more than 30 years
Sponsors
Leads: Medical University of Vienna

This content was sourced from clinicaltrials.gov